See What HealthDay Can Do For You
Contact Us

USPSTF Recommends Aspirin for Preventing Preeclampsia

Grade B recommendation applies to asymptomatic pregnant women at high risk of preeclampsia

USPSTF Recommends Aspirin for Preventing Preeclampsia

TUESDAY, Sept. 9, 2014 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin for preeclampsia prevention in high-risk pregnant women. The findings are presented in a final recommendation statement published online Sept. 9 in the Annals of Internal Medicine.

Researchers from the USPSTF reviewed the evidence relating to the effectiveness of low-dose aspirin for preventing preeclampsia in women at increased risk. In addition, they examined the maternal and fetal harms of low-dose aspirin use during pregnancy.

Based on the evidence, the USPSTF recommends the use of low-dose aspirin (81 mg/day) as a preventive measure after 12 weeks of gestation for women at high risk of preeclampsia (Grade B recommendation). The recommendation applies to asymptomatic pregnant women with increased preeclampsia risk, who have no contraindications or prior adverse reactions to low-dose aspirin.

"Most women are not at high risk for preeclampsia," Michael L. LeFevre, M.D., M.S.P.H., chair of the USPSTF, said in a statement. "Before taking aspirin, pregnant women should talk to their doctor or nurse to determine their risk level and discuss if taking aspirin is right for them."

Recommendation Statement

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.